Some CYDY events listed during various periods of certain

New Post Public Reply Private Reply Replies (0) Message Board
grow gestalt2 #96058
832
Some CYDY events listed during various periods of certain management & board members


Director, Caracciolo

September 11, 2012 Nadar Pourhassan named CEO
https://www.cytodyn.com/newsroom/press-releas...-announces

Director, Caracciolo
CEO, Pourhassan


July 30, 2012 Cytodyn buys pro140, Nader is CEO at that time
https://www.cytodyn.com/newsroom/press-releas...-progenics

June 17, 2013 Tony Caracciolo is named Chairman of the Board
https://www.cytodyn.com/newsroom/press-releas...hairman-of

COB, Caracciolo
CEO, Pourhassan


January 30, 2017 Tony Caracciolo is named Executive Chairman, effectively replacing Nader. Nader is still CEO, but Tony is in charge of planning, business development, and operations.
https://www.cytodyn.com/newsroom/press-releas...ppointment

COB & Executive Chairman, Caracciolo
CEO, Pourhassan


April 11, 2017 Scott Kelly appointed as Director
https://www.cytodyn.com/newsroom/press-releas...s-board-of

COB & Executive Chairman, Caracciolo
Director, Kelly
CEO, Pourhassan


July 12, 2018 Cytodyn signs letter of intent to purchase Prostagene & intent to appoint Pestell as Chief Medical Officer. AND ALSO Anthony Caracciolo has resigned his operating position as Executive Chairman and will continue to serve as Chairman of the Board
https://www.cytodyn.com/newsroom/press-releas...h-expanded

COB, Caracciolo
CEO, Pourhassan


August 18, 2018 Cytodyn agrees to buy Prostagene, Pestell becomes interim Chief Medical Officer
https://www.cytodyn.com/newsroom/press-releas...prostagene

COB, Caracciolo
CEO, Pourhassan
CMO (interim), Pestell


September 5, 2018 plan to develop mTNBC as initial cancer indication
https://www.cytodyn.com/newsroom/press-releas...metastatic

October 9, 2018 strategy to get test results on Prostagene 4 months after acquisition completes
https://www.cytodyn.com/newsroom/press-releas...t-of-novel

November 5, 2018 mTNBC trial protocol filed
https://www.cytodyn.com/newsroom/press-releas...2-clinical

November 19, 2018 Prostagene acquisition finalized, Pestell appointed to the Board and becomes Chief Science Officer
https://www.cytodyn.com/newsroom/press-releas...d-names-dr

COB, Caracciolo
CEO, Pourhassan
CMO & Director, Pestell


November 26 2018 mTNBC trial initiates (but 1st patient starts about 8 months later on 08/06/19
https://www.cytodyn.com/newsroom/press-releas...e-negative

December 12, 2018 Tony Caracciolo is replaced by Scott Kelly as Chairman of the Board
https://www.cytodyn.com/newsroom/press-releas...-the-board

COB, Kelly
Director, Caracciolo
CEO, Pourhassan
CMO & Director, Pestell


January 7, 2019 Pestell named as Vice Chairman of its Board of Directors
https://www.cytodyn.com/newsroom/press-releas...-d-as-vice

COB, Kelly
Director, Caracciolo
CEO, Pourhassan
CMO & Vice Chairman of Board, Pestell


January 10, 2019 Tony Caracciolo resigned as a member of the Company’s board of directors
https://www.sec.gov/edgar/search/?r=el#d688532d8k.htm

COB, Kelly
CEO, Pourhassan
CMO & Vice Chairman of Board, Pestell


June 19, 2019 filed FDA pre-submission application for Prostagene test
https://www.cytodyn.com/newsroom/press-releas...ion-to-u-s

June 24, 2019 FDA face-to-face meeting about Prostagene test
https://www.cytodyn.com/newsroom/press-releas...s-cytodyns

July 25, 2019 terminated the employment of Dr. Richard G. Pestell, the Company’s Chief Medical Officer, for cause pursuant to the terms of his employment agreement with the Company and effective immediately. Pursuant to the terms of his employment agreement, upon such termination, Dr. Pestell resigned from his position as a director of the Company. Dr. Pestell was not a member of any board committees.
https://www.sec.gov/Archives/edgar/data/00011...262d8k.htm

COB, Kelly
CEO, Pourhassan


July 26, 2019 IncellDX agreement executed
https://www.cytodyn.com/newsroom/press-releas...-agreement

COB, Kelly
CEO, Pourhassan
IncellDX agreement


August 6, 2019 first mTNBC patient treated
https://www.cytodyn.com/newsroom/press-releas...metastatic

August 22, 2019 Pestell sues Cytodyn
https://www.sec.gov/Archives/edgar/data/00011...060d8k.htm

April 27, 2020 completed BLA for HIV combo filed
https://www.cytodyn.com/newsroom/press-releas...pplication

May 8, 2020 FDA requires more data for BLA to address comments mentioned in March 2020 meeting.
https://www.cytodyn.com/newsroom/press-releas...pplication

July,13 2020 FDA issues Refusal to File letter. The FDA has informed the Company its BLA does not contain certain information needed to complete a substantive review and therefore, the FDA will not file the BLA at this time.
https://www.cytodyn.com/newsroom/press-releas...rmation-to


IMO It may be interesting to see what the FDA did say about the receptor occupancy listed in the application from 2020.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 27

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 25

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 26

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 12

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 30

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 15

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 19

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 36

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 23

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 23

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading

Top 5 Most Recently Viewed Articles

Jefferies Financial Group Set for Q3 Financial Results Release

Updated Category News Views 53

Jefferies Financial Group Set to Release Quarterly Results Jefferies Financial Group Inc. (NYSE: JEF) is gearing up to announce its third-quarter financial results, and both investors and analysts are eager for the news. This important announcement is expected after the market closes and will shed light on the company's financial stability and operational effectiveness....

Continue Reading
Joby Aviation Surges Amid Exciting New Government Program

Updated Category News Views 194

Joby Aviation Shares Rise Following Inclusion in New Program Joby Aviation Inc (NYSE: JOBY) has recently made headlines as its stock price rises following the announcement of its participation in a groundbreaking program aimed at integrating electric air taxis into U.S. airspace. What is the eVTOL Integration Pilot Program? The new eVTOL Integration Pilot Program is a...

Continue Reading
Interactive Fitness Market Expected to Surge to $10.03 Billion

Updated Category News Views 166

Understanding the Growth of the Interactive Fitness Market SkyQuest Technology has reported that the interactive fitness market is set to experience significant growth, reaching a valuation of USD 10.03 billion by 2031. This transition is fueled by a robust compound annual growth rate (CAGR) of 8.5% from 2024 to 2031. As lifestyles become increasingly sedentary due to...

Continue Reading
Royalty Pharma Shares Exciting Updates from Healthcare Forum

Updated Category News Views 169

Royalty Pharma Engages at Notable Healthcare Forum Royalty Pharma plc (NASDAQ: RPRX) recently announced its participation in a fireside chat at Bernstein's 2nd Annual Healthcare Forum. The event is set to take place on an upcoming Tuesday, where the team will discuss crucial developments, strategic insights, and the company’s impact on the biopharmaceutical landscape....

Continue Reading
Exploring the Future of the Clear Aligners Industry

Updated Category News Views 76

The Rise of Clear Aligners in Modern Orthodontics Clear aligners are becoming a go-to solution for many looking to perfect their smiles. According to a recent analysis, the market for these innovative orthodontic devices is projected to skyrocket, achieving a remarkable valuation of USD 43.4 billion by 2031. What's driving this rapid growth? The answer lies in a...

Continue Reading